Guardant Health (GH) Stock: Buy, Sell, or Hold?
$154.78
-0.57 (-0.37%)
▼
5d:
-8.19%
30d:
-4.51%
90d:
-2.98%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 05, 2026
0d
Protect GH Gains
Updated Nov 11, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (83%)
Quality Score
51/100
Position
OVERSOLD
30-Day Fair Range
$157.68 – $176.34
Position: OVERSOLD
Forward P/E & Valuation
-543.9x
Next 12M consensus est.
Wall Street Target
$200.88
+29.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$136.42 / $186.01
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: GH shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When GH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: GH is currently trading at $154.78, which is considered oversold relative to its 30-day fair value range of $157.68 to $176.34.
Technical Outlook: Technically, GH is in a uptrend. Immediate support is located at $136.42, while resistance sits at $186.01.
Market Sentiment: The stock scores a mixed 41/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $200.88 (+29.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GH is in a uptrend. Immediate support is located at $136.42, while resistance sits at $186.01.
Market Sentiment: The stock scores a mixed 41/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $200.88 (+29.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$157.68 -
$176.34
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
Trading Range & Key Levels
30-Day Trading Range
$157.68 -
$176.34
Current vs Trading Range
OVERSOLD
Support Level
$136.42
Resistance Level
$186.01
Current Trend
Uptrend
Technical data as of
Nov 11, 2026
Protect Your Profits
Holding GH? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (41/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 29.8% below Wall St target ($200.88)
- WARNING: Composite score 51/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-543.85
Wall Street Target
$200.88
(+29.8%)
Revenue Growth (YoY)
36.1%
Profit Margin
-37.9%
Share GH Analysis
Share this live GH analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (GH)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 7, 2026
Daily AI digest
AI Retail Discussion Summary:
Quest Diagnostics, the IBD Stock of the Day, is bucking the medtech trend with shares in a buy zone despite election-related worries in the healthcare sector.
Key Retail Themes:
Medtech sector trends
Quest Diagnostics' strong performance
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 2:53 AM ET
Data refreshes hourly during market hours. Next update: 3:53 AM
Data refreshes hourly during market hours. Next update: 3:53 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTRA
Natera Inc |
STRONG BUY
23 analysts |
$416 | 65 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
27 analysts |
$752 | 47 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
24 analysts |
$260 | 51 HOLD |
|
IQV
IQVIA Holdings Inc |
STRONG BUY
20 analysts |
$312 | 57 HOLD |
Advanced GH Option Strategies
Professional options setups generated by AI based on today's GH price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive GH Research Pages
